Background: Dental plaque is a breeding ground for Phorphyromonas gingivalis bacteria which causes periodontal disease. Chitosan is a compound derived from the deacetylation of chitin in marine animals such as shrimp which has been proven to be antibacterial, non-toxic, biocompatible and biodegradable. During pregnancy there is an increase in acid levels in the oral cavity, as well as exposure to stomach acid on the teeth and gingiva which results in inflammation of the gingiva and periodontal tissue. This study aims to determine the activity of chitosan in inhibiting the growth of Phorphyromonas gingivalis bacteria in postnatal mothers with periodontal disease. Method: True experimental randomized pre-test and post-test control group design, with topical administration of 2% chitosan gel to mothers with gingivitis in Badung Regency, Bali. The sample was 14 postpartum mothers, divided into control groups (given base gel) and treatment (2% chitosan gel). The degree of gingivitis is measured using Modified Gingival Indexes (MGI), for antibacterial by calculating the number of Phorphyromonas gingivalis deoxyribonucleic acid (DNA) copies using Real Time Polymerase Chain Reaction (RT-PCR). Results: Descriptively, there was a difference in the decrease in the average MGI index in the control and treatment groups on the 7th and 21st days, as well as in the average number of bacteria. The Wilcoxon test showed p<0.05, in the control and treatment groups, meaning there was a significant decrease in the MGI index on the 7th and 21st days. Calculation of the number of Phorphyromonas gingivalis bacteria showed p<0.05, meaning there was a decrease in the number in the control and treatment groups. However, the Mann Whitney test results showed p>0.05, meaning there was no significant relationship between the control and treatment groups, either on the MGI index or the number of Phorphyromonas gingivalis bacteria. Conclusion: Vaname 2% shrimp chitosan gel has anti-inflammatory and antibacterial properties.
Read full abstract